Equipped with most advanced Distributed Control System (DCS) automation technology, the facility has been set up with an investment of Rs. 200 crore
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
Lokavant provides clinical trial intelligence
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
New Board of Directors and management team at Suven Pharma also appointed
The product is expected to start contributing meaningfully to the revenue from FY25
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Subscribe To Our Newsletter & Stay Updated
